Immunogenicity of aIIV3, MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine, in Older Adults ≥65 Years of Age: Meta-Analysis of Cumulative Clinical Experience
Immunogenicity of aIIV3, MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine, in Older Adults ≥65 Years of Age: Meta-Analysis of Cumulative Clinical Experience
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search